Skip to main content

Table 5 Baseline characteristics and pregnancy outcomes of studied patients without PCOS

From: Effect of body mass index on pregnancy outcomes in young women with low-prognosis POSEIDON criteria after in vitro fertilization/intracytoplasmic sperm injection

 

Underweight

n = 505

Normal weight

n = 3284

Overweight

n = 1241

Obese

n = 555

P

AFC

8.48 ± 4.35

9.08 ± 4.7

9.83 ± 5.24

11.18 ± 6.09

 < 0.001 abcdef*

AMH (ng/ml)

2.19 ± 2.01

2.28 ± 2.23

2.48 ± 2.42

2.57 ± 2.37

0.003 bcde

Basal serum FSH level (mIU/ml)

8.5 ± 4.2

7.52 ± 3.72

7.07 ± 7.58

6.4 ± 2.41

 < 0.001 abcdef

Implantation rate of fresh ET n (%)

210(31.3)

1413(31.2)

557(32.7)

226(29.6)

0.450

Cumulative implantation rate n (%)

278(33.2)

1806(32.7)

710(33.6)

287(31.7)

0.759

Clinical pregnancy rate of fresh ET n (%)

160(43.8)

1094(44.2)

419(45.2)

177(41.7)

0.700

Cumulative clinical pregnancy rate n (%)

219(54.1)

1433(53.7)

545(53.8)

225(50.0)

0.514

Miscarriage rate of fresh ET n (%)

18(11.3)

138(12.6)

54(12.6)

41(23.2)

0.001cef

Live birth rate of fresh ET n (%)

138(37.8)

927(37.4)

355(38.3)

130(30.7)

0.041abcef

Cumulative live birth rate n (%)

192(47.4)

1248(46.7)

469(46.3)

171(38.0)

0.006 cef

  1. *: Data are shown as the number of patients (percentage) or mean ± SD. SD, standard deviation; PCOS, polycystic ovary syndrome; AFC, antral follicular count; AMH, anti-Müllerian hormone; FSH, follicular stimulating hormone. a P < 0.05, underweight vs. normal weight; b P < 0.05, underweight vs. overweight; c P < 0.05, underweight vs. obese; d P < 0.05, normal weight vs. overweight; e P < 0.05, normal weight vs. obese; f P < 0.05, overweight vs. obese